{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:01:33Z","timestamp":1791478893967,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YD2060002502"],"award-info":[{"award-number":["YD2060002502"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YD9100002033"],"award-info":[{"award-number":["YD9100002033"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB39000000"],"award-info":[{"award-number":["XDB39000000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031910","name":"Changping Laboratory","doi-asserted-by":"publisher","award":["2025B-07-05"],"award-info":[{"award-number":["2025B-07-05"]}],"id":[{"id":"10.13039\/100031910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031910","name":"Changping Laboratory","doi-asserted-by":"publisher","award":["2025B-07-20"],"award-info":[{"award-number":["2025B-07-20"]}],"id":[{"id":"10.13039\/100031910","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.scib.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:07:53Z","timestamp":1785996473000},"page":"4506-4515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Head-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohort"],"prefix":"10.1016","volume":"71","author":[{"given":"Xinyi","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2026.08.018_b0005","article-title":"World Alzheimer Report 2022: Life after diagnosis: navigating treatment, care and support","author":"Gauthier","year":"2022","journal-title":"Alzheimer\u2019s Disease International"},{"key":"10.1016\/j.scib.2026.08.018_b0010","article-title":"Alzheimer\u2019s disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.medp.2025.100112","article-title":"Advancement of disease-modifying therapy of Alzheimer\u2019s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer\u2019s disease","volume":"2","author":"Wu","year":"2025","journal-title":"Med Plus"},{"key":"10.1016\/j.scib.2026.08.018_b0020","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0025","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1016\/j.scib.2024.09.042","article-title":"Now and future: strategies for diagnosis, prevention and therapies for Alzheimer's disease","volume":"69","author":"Shi","year":"2024","journal-title":"Sci Bull"},{"key":"10.1016\/j.scib.2026.08.018_b0030","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0035","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1002\/alz.14184","article-title":"Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0040","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer disease as a clinical-biological construct\u2014an international working group recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0050","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.scib.2023.07.009","article-title":"Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China","volume":"68","author":"Gao","year":"2023","journal-title":"Sci Bull"},{"key":"10.1016\/j.scib.2026.08.018_b0055","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1016\/j.scib.2025.10.044","article-title":"Performance of blood biomarkers in internal jugular vein for Alzheimer's disease pathologies: the delta method study","volume":"70","author":"Wang","year":"2025","journal-title":"Sci Bull"},{"key":"10.1016\/j.scib.2026.08.018_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100474","article-title":"Cost-effectiveness analysis of blood-based biomarker testing in the diagnosis of Alzheimer\u2019s disease pathology","volume":"13","author":"Li","year":"2026","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.scib.2026.08.018_b0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.scib.2026.08.018_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14458","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: a systematic review and meta-analysis","volume":"21","author":"Khalafi","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.scib.2026.08.018_b0080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.scib.2026.08.018_b0085","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/awae368","article-title":"Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison","volume":"148","author":"Pilotto","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.scib.2026.08.018_b0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s43587-025-00835-z","article-title":"Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials","volume":"5","author":"Ossenkoppele","year":"2025","journal-title":"Nat Aging"},{"key":"10.1016\/j.scib.2026.08.018_b0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14536","article-title":"Plasma p-tau217 and p-tau217\/A\u03b21-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: insights for research and clinical practice","volume":"21","author":"Zhong","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0105","unstructured":"US Food and Drug Administration. 510(k) Decision Summary: Lumipulse G pTau217\/\u03b2-Amyloid 1-42 Plasma Ratio (K242706). 2025."},{"key":"10.1016\/j.scib.2026.08.018_b0110","article-title":"Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings","volume":"21","author":"Palmqvist","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00415-025-12996-3","article-title":"Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer\u2019s disease continuum. A systematic review and meta-analysis","volume":"272","author":"Antonioni","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0120","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","article-title":"Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"24","author":"Therriault","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105405","article-title":"Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform","volume":"109","author":"Feizpour","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.scib.2026.08.018_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.medp.2024.100057","article-title":"Blood-based biomarkers of Alzheimer\u2019s disease\u2014a guideline for clinical use","volume":"1","author":"Shi","year":"2024","journal-title":"Med Plus"},{"key":"10.1016\/j.scib.2026.08.018_b0135","article-title":"Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer's disease in clinical and community cohorts","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105805","article-title":"Comparative performance of plasma pTau181\/A\u03b242, pTau217\/A\u03b242 ratios, and individual measurements in detecting brain amyloidosis","volume":"117","author":"Lehmann","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.scib.2026.08.018_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70469","article-title":"Comparison of plasma p-tau217\/A\u03b242, p-tau217, and A\u03b242\/A\u03b240 biomarkers by race to detect Alzheimer's disease","volume":"21","author":"Cousins","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0150","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform","volume":"31","author":"Palmqvist","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.scib.2026.08.018_b0155","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/brain\/awae346","article-title":"A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests","volume":"148","author":"Warmenhoven","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.scib.2026.08.018_b0165","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/alz.13542","article-title":"Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","volume":"20","author":"Rissman","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0170","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1002\/alz.13764","article-title":"Clinical validation of the PrecivityAD2 blood test: a mass spectrometry-based test with algorithm combining %p-tau217 and A\u03b242\/40 ratio to identify presence of brain amyloid","volume":"20","author":"Meyer","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0175","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jnnp-2025-335830","article-title":"Tailoring thresholds for interpreting plasma p-tau217 levels","volume":"96","author":"Ahn","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.scib.2026.08.018_b0180","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70182","article-title":"Profiling plasma biomarkers, particularly pTau217 and pTau217\/A\u03b242, and their relation to cognition in memory clinic patients","volume":"169","author":"Bucci","year":"2025","journal-title":"J Neurochem"},{"key":"10.1016\/j.scib.2026.08.018_b0185","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1002\/alz.14140","article-title":"Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays","volume":"20","author":"Figdore","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology\u2014recommendations from the global CEO initiative on Alzheimer\u2019s disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.scib.2026.08.018_b0205","article-title":"The two cut-offs approach for plasma p-tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairment","volume":"17","author":"Giacomucci","year":"2025","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.scib.2026.08.018_b0210","doi-asserted-by":"crossref","first-page":"16316","DOI":"10.1038\/s41598-025-01511-3","article-title":"Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unit","volume":"15","author":"\u00c1lvarez-S\u00e1nchez","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.scib.2026.08.018_b0215","doi-asserted-by":"crossref","first-page":"e261565","DOI":"10.1001\/jamaneurol.2026.1565","article-title":"Variability in clinical performance of the FDA-cleared Lumipulse P-Tau217\/\u03b2-amyloid 1-42 plasma ratio","volume":"83","author":"Algeciras-Schimnich","year":"2026","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.scib.2026.08.018_b0220","doi-asserted-by":"crossref","first-page":"e108585","DOI":"10.1002\/alz70861_108585","article-title":"Clinical performance and effect of pre-analytical variation of plasma pTau217 alone versus the plasma pTau217\/A\u03b242 ratio for the identification of amyloid pathology","volume":"21","author":"Rank","year":"2025","journal-title":"Alzheimers Dement"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326008844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927326008844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:35:23Z","timestamp":1789590923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927326008844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2095927326008844"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2026.08.018","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohort","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. and Science China Press.","name":"copyright","label":"Copyright"}]}}